Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium
about
Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis.Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasisCarcinoembryonic antigen and CD44 variant isoforms cooperate to mediate colon carcinoma cell adhesion to E- and L-selectin in shear flowTargeting selectins and selectin ligands in inflammation and cancerInteraction between circulating cancer cells and platelets: clinical implicationPlatelet integrin α6β1 controls lung metastasis through direct binding to cancer cell-derived ADAM9.Chondroitin sulfate glycosaminoglycans as major P-selectin ligands on metastatic breast cancer cell linesTrousseau's syndrome: multiple definitions and multiple mechanismsProstatic cell-specific regulation of the synthesis of MUC1-associated sialyl Lewis aDifferential inhibition of tumour cell-induced platelet aggregation by the nicotinate aspirin prodrug (ST0702) and aspirin.5-Aza-2'-deoxycytidine increases sialyl Lewis X on MUC1 by stimulating β-galactoside:α2,3-sialyltransferase 6 gene.PDGFRB promotes liver metastasis formation of mesenchymal-like colorectal tumor cellsE-selectin liposomal and nanotube-targeted delivery of doxorubicin to circulating tumor cells.The high affinity selectin glycan ligand C2-O-sLex and mRNA transcripts of the core 2 beta-1,6-N-acetylglucosaminyltransferase (C2GnT1) gene are highly expressed in human colorectal adenocarcinomas.Platelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond.Sialyl Lewis(x)-mediated, PSGL-1-independent rolling adhesion on P-selectin.P-selectin, carcinoma metastasis and heparin: novel mechanistic connections with therapeutic implications.Sialylated Lewis x antigen bearing glycoproteins in human plasmaPhenotypic switch in blood: effects of pro-inflammatory cytokines on breast cancer cell aggregation and adhesionPlatelet--cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation.The evolving role of platelets in inflammation.Carcinoma mucins trigger reciprocal activation of platelets and neutrophils in a murine model of Trousseau syndrome.Selectins facilitate carcinoma metastasis and heparin can prevent them.Cancer cell adhesion and metastasis: selectins, integrins, and the inhibitory potential of heparinsVascular Targeting of a Gold Nanoparticle to Breast Cancer Metastasis.Glycosyltransferases involved in the synthesis of MUC-associated metastasis-promoting selectin ligands.Spatiotemporal Targeting of a Dual-Ligand Nanoparticle to Cancer Metastasis.Expression of E-selectin ligands on circulating tumor cells: cross-regulation with cancer stem cell regulatory pathways?Dynamic biochemical tissue analysis detects functional L-selectin ligands on colon cancer tissues.Pathobiological implications of mucin glycans in cancer: Sweet poison and novel targets.The initial hours of metastasis: the importance of cooperative host-tumor cell interactions during hematogenous disseminationEffects of shear on P-selectin deposition in microfluidic channelsThe tumor cell-host organ interface in the early onset of metastatic organ colonisation.Glycan antagonists and inhibitors: a fount for drug discovery.Cancer and the metastatic substrate.Altered tumor-cell glycosylation promotes metastasis.Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progressionMalignant melanoma as a target malignancy for the study of the anti-metastatic properties of the heparins.Glycomechanics of the metastatic cascade: tumor cell-endothelial cell interactions in the circulation.Nanobiotechnology for the capture and manipulation of circulating tumor cells.
P2860
Q24529958-1B181648-DA0D-4369-B68B-1140A2F53504Q24630993-4118925D-7588-4873-A54C-B8887CE391ECQ24644116-BE5D2E90-5691-4BAA-9E1A-3E4E2E73C7B8Q24658204-7B3557E0-7B5F-44C8-8DDE-0588A841EE7AQ26778920-527D911E-ADA9-4BD4-9249-43B5C2495DBFQ27333563-4C7B67A9-8318-44D7-A949-C0117512876AQ28277833-115DC995-B76F-413F-9E1B-296F749949FFQ28301882-E8D7EB2C-D9BA-4E3D-8920-5AB4B6B34E46Q28486623-A80C4BBD-8946-4208-B847-1E878F12BA5AQ30453962-3123DBFD-0BD1-40D8-B373-6A4EA92B418DQ30499157-4CBFA224-4616-4536-9893-51875279BD25Q30536377-D131C138-98F9-477A-879D-FF24CF347DDDQ30543323-7598FAE2-C9D7-4183-9F71-139ECC93189EQ33415704-9133CEE4-E0C2-49F6-8E42-A54FE6F4F8F0Q33432917-D88F1F66-5910-4E7D-AB42-FE1020CD2526Q34173603-0CF61F54-5587-49E2-9D65-329FF404CE4CQ34265306-D9DB6CF2-8F67-4BE6-9F4E-293FFFFD6712Q34289582-A49EC7FD-9592-415F-87F7-0A462DC46BD8Q34571490-AB6F29CD-D42D-40C8-93BC-D6009E4389AFQ35048404-1D34A92B-CA61-4370-B258-9B63E698BCA3Q35206747-FD97AD33-EE5F-4A66-9415-FFA3FB293DD9Q35483514-C00BD975-EFAC-4F76-A445-9415DEC690B2Q35636253-383F8A4E-F94A-4958-879D-A59F57B8E9A6Q35810537-10B3130D-26A5-4D1B-99B9-6FFF86CBF26DQ35858759-3F1A7EBB-2486-4E5B-9D05-EF13EC4BA6C2Q35899406-352640ED-582D-4A5B-91A0-F67DF47D5227Q36084803-46851591-4361-49C9-9A26-F6F5AF470783Q36175119-4B61C43C-12C0-4E10-B462-FEDA0029199BQ36304453-A058709D-E8D6-46D3-9F93-7D2A36C48204Q36328299-97E99229-8098-4883-B7E7-C5953C7A1CD4Q36520882-8372010C-D868-4B08-B910-B2A0157FAC3BQ36853357-BED0D19E-7821-42DC-AD09-6C54FE731EF1Q37023821-6BC82B37-3BA4-44E4-8774-462038FEAAA8Q37027396-8CD688AD-CDF6-4350-BC8D-341C8BF9BAB2Q37573461-1D43C5DE-2F96-49A1-87F6-5F854E9FD019Q37581540-00048A45-A38C-4453-92C9-58A96115F919Q37671122-F47C5870-EB4E-430D-AF53-CE89FF785A5AQ37799290-BADE496A-FDAD-49A7-9ED6-A9A9E90A4700Q37958726-FDF74FC3-1DD8-463A-804B-F5FBAAF281DAQ37967661-16E04652-1F82-4413-A59D-57EFBB29E707
P2860
Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Distinct selectin ligands on c ...... s, leukocytes, and endothelium
@en
type
label
Distinct selectin ligands on c ...... s, leukocytes, and endothelium
@en
prefLabel
Distinct selectin ligands on c ...... s, leukocytes, and endothelium
@en
P2093
P2860
P1476
Distinct selectin ligands on c ...... s, leukocytes, and endothelium
@en
P2093
P2860
P304
P356
10.1016/S0002-9440(10)65142-5
P407
P50
P577
1999-08-01T00:00:00Z